BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 15585401)

  • 1. mda-7/IL-24: exploiting cancer's Achilles' heel.
    Lebedeva IV; Sauane M; Gopalkrishnan RV; Sarkar D; Su ZZ; Gupta P; Nemunaitis J; Cunningham C; Yacoub A; Dent P; Fisher PB
    Mol Ther; 2005 Jan; 11(1):4-18. PubMed ID: 15585401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytokine and tumor cell apoptosis inducing activity of mda-7/IL-24.
    Gopalkrishnan RV; Sauane M; Fisher PB
    Int Immunopharmacol; 2004 May; 4(5):635-47. PubMed ID: 15120649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. mda-7 (IL-24): signaling and functional roles.
    Sarkar D; Su ZZ; Lebedeva IV; Sauane M; Gopalkrishnan RV; Dent P; Fisher PB
    Biotechniques; 2002 Oct; Suppl():30-9. PubMed ID: 12395925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is mda-7/IL-24 a "magic bullet" for cancer?
    Fisher PB
    Cancer Res; 2005 Nov; 65(22):10128-38. PubMed ID: 16287994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanistic aspects of mda-7/IL-24 cancer cell selectivity analysed via a bacterial fusion protein.
    Sauane M; Gopalkrishnan RV; Choo HT; Gupta P; Lebedeva IV; Yacoub A; Dent P; Fisher PB
    Oncogene; 2004 Oct; 23(46):7679-90. PubMed ID: 15334067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unique aspects of mda-7/IL-24 antitumor bystander activity: establishing a role for secretion of MDA-7/IL-24 protein by normal cells.
    Su Z; Emdad L; Sauane M; Lebedeva IV; Sarkar D; Gupta P; James CD; Randolph A; Valerie K; Walter MR; Dent P; Fisher PB
    Oncogene; 2005 Nov; 24(51):7552-66. PubMed ID: 16044151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. mda-7/IL-24, novel anticancer cytokine: focus on bystander antitumor, radiosensitization and antiangiogenic properties and overview of the phase I clinical experience (Review).
    Lebedeva IV; Emdad L; Su ZZ; Gupta P; Sauane M; Sarkar D; Staudt MR; Liu SJ; Taher MM; Xiao R; Barral P; Lee SG; Wang D; Vozhilla N; Park ES; Chatman L; Boukerche H; Ramesh R; Inoue S; Chada S; Li R; De Pass AL; Mahasreshti PJ; Dmitriev IP; Curiel DT; Yacoub A; Grant S; Dent P; Senzer N; Nemunaitis JJ; Fisher PB
    Int J Oncol; 2007 Nov; 31(5):985-1007. PubMed ID: 17912425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of the Fas-FasL signaling pathway by MDA-7/IL-24 kills human ovarian cancer cells.
    Gopalan B; Litvak A; Sharma S; Mhashilkar AM; Chada S; Ramesh R
    Cancer Res; 2005 Apr; 65(8):3017-24. PubMed ID: 15833826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Melanoma differentiation-associated gene-7 (mda-7)/interleukin (IL)-24 induces anticancer immunity in a syngeneic murine model.
    Miyahara R; Banerjee S; Kawano K; Efferson C; Tsuda N; Miyahara Y; Ioannides CG; Chada S; Ramesh R
    Cancer Gene Ther; 2006 Aug; 13(8):753-61. PubMed ID: 16543916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ionizing radiation enhances therapeutic activity of mda-7/IL-24: overcoming radiation- and mda-7/IL-24-resistance in prostate cancer cells overexpressing the antiapoptotic proteins bcl-xL or bcl-2.
    Su ZZ; Lebedeva IV; Sarkar D; Emdad L; Gupta P; Kitada S; Dent P; Reed JC; Fisher PB
    Oncogene; 2006 Apr; 25(16):2339-48. PubMed ID: 16331261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. mda-7/IL-24 inhibits the proliferation of hematopoietic malignancies in vitro and in vivo.
    Dong CY; Zhang F; Duan YJ; Yang BX; Lin YM; Ma XT
    Exp Hematol; 2008 Aug; 36(8):938-46. PubMed ID: 18468766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. mda-7/IL24 kills pancreatic cancer cells by inhibition of the Wnt/PI3K signaling pathways: identification of IL-20 receptor-mediated bystander activity against pancreatic cancer.
    Chada S; Bocangel D; Ramesh R; Grimm EA; Mumm JB; Mhashilkar AM; Zheng M
    Mol Ther; 2005 May; 11(5):724-33. PubMed ID: 15851011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The antitumor activity of TRAIL and IL-24 with replicating oncolytic adenovirus in colorectal cancer.
    Zhao L; Dong A; Gu J; Liu Z; Zhang Y; Zhang W; Wang Y; He L; Qian C; Qian Q; Liu X
    Cancer Gene Ther; 2006 Nov; 13(11):1011-22. PubMed ID: 16799468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intratumoral injection of INGN 241, a nonreplicating adenovector expressing the melanoma-differentiation associated gene-7 (mda-7/IL24): biologic outcome in advanced cancer patients.
    Tong AW; Nemunaitis J; Su D; Zhang Y; Cunningham C; Senzer N; Netto G; Rich D; Mhashilkar A; Parker K; Coffee K; Ramesh R; Ekmekcioglu S; Grimm EA; van Wart Hood J; Merritt J; Chada S
    Mol Ther; 2005 Jan; 11(1):160-72. PubMed ID: 15585417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adenovirus vector expressing mda-7 selectively kills hepatocellular carcinoma cell line Hep3B.
    Xue XB; Chen K; Wang CJ; Zheng JW; Yu Y; Peng ZH; Wu ZD
    Hepatobiliary Pancreat Dis Int; 2008 Oct; 7(5):509-14. PubMed ID: 18842498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of adenovirus-mediated mda-7/IL-24 gene infection on apoptosis of drug-resistant human ovarian cancer cell lines OVCAR-3 and OVCAR-8/TR].
    Xiong J; Peng ZL; Tan X; Yan NH
    Ai Zheng; 2007 Apr; 26(4):371-6. PubMed ID: 17430654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel pathway involving melanoma differentiation associated gene-7/interleukin-24 mediates nonsteroidal anti-inflammatory drug-induced apoptosis and growth arrest of cancer cells.
    Zerbini LF; Czibere A; Wang Y; Correa RG; Otu H; Joseph M; Takayasu Y; Silver M; Gu X; Ruchusatsawat K; Li L; Sarkar D; Zhou JR; Fisher PB; Libermann TA
    Cancer Res; 2006 Dec; 66(24):11922-31. PubMed ID: 17178890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting inhibition of K-ras enhances Ad.mda-7-induced growth suppression and apoptosis in mutant K-ras colorectal cancer cells.
    Lebedeva IV; Su ZZ; Emdad L; Kolomeyer A; Sarkar D; Kitada S; Waxman S; Reed JC; Fisher PB
    Oncogene; 2007 Feb; 26(5):733-44. PubMed ID: 16924242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conditionally replicating adenoviruses carrying mda-7/IL-24 for cancer therapy.
    Jiang G; Zhang L; Xin Y; Pei DS; Wei ZP; Liu YQ; Zheng JN
    Acta Oncol; 2012 Mar; 51(3):285-92. PubMed ID: 21995527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p51/p63, a novel p53 homologue, potentiates p53 activity and is a human cancer gene therapy candidate.
    Kunisaki R; Ikawa S; Maeda T; Nakazaki Y; Kurita R; Harata M; Shutoh Y; Bai YS; Soda Y; Tanabe T; Dohi T; Kato R; Ikawa Y; Asano S; Tani K
    J Gene Med; 2006 Sep; 8(9):1121-30. PubMed ID: 16832836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.